This site is intended for healthcare professionals
Journals
  • Home
  • /
  • Journals
  • /
  • Other lower respiratory disease
  • /
  • Under-recognised co-morbidities in idiopathic pulm...
Journal

Under-recognised co-morbidities in idiopathic pulmonary fibrosis: A review.

Read time: 1 mins
Published:1st Aug 2016
Author: de Boer K, Lee JS.
Source: Respirology
Availability: Free full text
Ref.:Respirology. 2016;21(6):995-1004.
DOI:10.1111/resp.12622

Co-morbidities in idiopathic pulmonary fibrosis are common. These co-morbidities include obstructive sleep apnoea, gastro-oesophageal reflux disease, pulmonary hypertension and depression. The presence of co-morbidities among patients with idiopathic pulmonary fibrosis contributes to worse quality of life, morbidity and mortality. Despite the high prevalence of certain co-morbidities in idiopathic pulmonary fibrosis, the optimal screening and management of many of these conditions remains unclear. The impact of co-morbidities on this patient population is becoming more apparent. Their relevance will only increase as significant effort is being made to develop novel therapeutics that will alter the disease trajectory of patients with idiopathic pulmonary fibrosis. The purpose of this review is to focus on the epidemiology, pathophysiology, diagnosis and management of select co-morbidities, including obstructive sleep apnoea, gastro-oesophageal reflux disease, pulmonary hypertension and depression, in idiopathic pulmonary fibrosis.

 

Read abstract on library site

Access full article